Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18 11 Medical and Health Sciences 1108 Medical Microbiology

Autores
Molina, Diego; Cossio Pérez, Rodrigo; Rocha Roa, Cristian Camilo; Pedraza, Lina; Cortes, Edwar; Hernández, Alejandro; Gómez Marín, Jorge E.
Año de publicación
2018
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Background: Thiazolidinone derivatives show inhibitory activity (IC 50 ) against the Toxoplasma gondii parasite, as well as high selectivity with high therapeutic index. To disclose the target proteins of the thiazolidinone core in this parasite, we explored in silico the active sites of different T. gondii proteins and estimated the binding-free energy of reported thiazolidinone molecules with inhibitory effect on invasion and replication of the parasite inside host cells. This enabled us to describe some of the most suitable structural characteristics to design a compound derived from the thiazolidinone core. Results: The best binding affinity was observed in the active site of kinase proteins, we selected the active site of the T. gondii ROP18 kinase, because it is an important factor for the virulence and survival of the parasite. We present the possible effect of a derivative of thiazolidinone core in the active site of T. gondii ROP18 and described some characteristics of substituent groups that could improve the affinity and specificity of compounds derived from the thiazolidinone core against T. gondii. Conclusions: The results of our study suggest that compounds derived from the thiazolidinone core have a preference for protein kinases of T. gondii, being promising compounds for the development of new drugs with potential anti-toxoplasmosis activity. Our findings highlight the importance of use computational studies for the understanding of the action mechanism of compounds with biological activity.
Fil: Molina, Diego. Universidad del Quindio; Colombia
Fil: Cossio Pérez, Rodrigo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Quilmes. Departamento de Ciencia y Tecnología; Argentina
Fil: Rocha Roa, Cristian Camilo. Universidad del Quindío; Armenia
Fil: Pedraza, Lina. Universidad del Quindio; Colombia
Fil: Cortes, Edwar. Universidad del Quindio; Colombia
Fil: Hernández, Alejandro. Universidad del Quindio; Colombia
Fil: Gómez Marín, Jorge E.. Universidad del Quindio; Colombia
Materia
RHOPTRY PROTEINS
THIAZOLIDINONE
TOXOPLASMA GONDII
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/98354

id CONICETDig_e0ab5f1362afa3cf67a003a96854ac80
oai_identifier_str oai:ri.conicet.gov.ar:11336/98354
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18 11 Medical and Health Sciences 1108 Medical MicrobiologyMolina, DiegoCossio Pérez, RodrigoRocha Roa, Cristian CamiloPedraza, LinaCortes, EdwarHernández, AlejandroGómez Marín, Jorge E.RHOPTRY PROTEINSTHIAZOLIDINONETOXOPLASMA GONDIIhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Background: Thiazolidinone derivatives show inhibitory activity (IC 50 ) against the Toxoplasma gondii parasite, as well as high selectivity with high therapeutic index. To disclose the target proteins of the thiazolidinone core in this parasite, we explored in silico the active sites of different T. gondii proteins and estimated the binding-free energy of reported thiazolidinone molecules with inhibitory effect on invasion and replication of the parasite inside host cells. This enabled us to describe some of the most suitable structural characteristics to design a compound derived from the thiazolidinone core. Results: The best binding affinity was observed in the active site of kinase proteins, we selected the active site of the T. gondii ROP18 kinase, because it is an important factor for the virulence and survival of the parasite. We present the possible effect of a derivative of thiazolidinone core in the active site of T. gondii ROP18 and described some characteristics of substituent groups that could improve the affinity and specificity of compounds derived from the thiazolidinone core against T. gondii. Conclusions: The results of our study suggest that compounds derived from the thiazolidinone core have a preference for protein kinases of T. gondii, being promising compounds for the development of new drugs with potential anti-toxoplasmosis activity. Our findings highlight the importance of use computational studies for the understanding of the action mechanism of compounds with biological activity.Fil: Molina, Diego. Universidad del Quindio; ColombiaFil: Cossio Pérez, Rodrigo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Quilmes. Departamento de Ciencia y Tecnología; ArgentinaFil: Rocha Roa, Cristian Camilo. Universidad del Quindío; ArmeniaFil: Pedraza, Lina. Universidad del Quindio; ColombiaFil: Cortes, Edwar. Universidad del Quindio; ColombiaFil: Hernández, Alejandro. Universidad del Quindio; ColombiaFil: Gómez Marín, Jorge E.. Universidad del Quindio; ColombiaBioMed Central2018-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/98354Molina, Diego; Cossio Pérez, Rodrigo; Rocha Roa, Cristian Camilo; Pedraza, Lina; Cortes, Edwar; et al.; Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18 11 Medical and Health Sciences 1108 Medical Microbiology; BioMed Central; BMC Genomics; 19; 1; 11-2018; 1-181471-2164CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1186/s12864-018-5223-7info:eu-repo/semantics/altIdentifier/url/https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-018-5223-7info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2026-08-25T14:39:59Zoai:ri.conicet.gov.ar:11336/98354instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982026-08-25 14:40:00.289CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18 11 Medical and Health Sciences 1108 Medical Microbiology
title Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18 11 Medical and Health Sciences 1108 Medical Microbiology
spellingShingle Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18 11 Medical and Health Sciences 1108 Medical Microbiology
Molina, Diego
RHOPTRY PROTEINS
THIAZOLIDINONE
TOXOPLASMA GONDII
title_short Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18 11 Medical and Health Sciences 1108 Medical Microbiology
title_full Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18 11 Medical and Health Sciences 1108 Medical Microbiology
title_fullStr Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18 11 Medical and Health Sciences 1108 Medical Microbiology
title_full_unstemmed Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18 11 Medical and Health Sciences 1108 Medical Microbiology
title_sort Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18 11 Medical and Health Sciences 1108 Medical Microbiology
dc.creator.none.fl_str_mv Molina, Diego
Cossio Pérez, Rodrigo
Rocha Roa, Cristian Camilo
Pedraza, Lina
Cortes, Edwar
Hernández, Alejandro
Gómez Marín, Jorge E.
author Molina, Diego
author_facet Molina, Diego
Cossio Pérez, Rodrigo
Rocha Roa, Cristian Camilo
Pedraza, Lina
Cortes, Edwar
Hernández, Alejandro
Gómez Marín, Jorge E.
author_role author
author2 Cossio Pérez, Rodrigo
Rocha Roa, Cristian Camilo
Pedraza, Lina
Cortes, Edwar
Hernández, Alejandro
Gómez Marín, Jorge E.
author2_role author
author
author
author
author
author
dc.subject.none.fl_str_mv RHOPTRY PROTEINS
THIAZOLIDINONE
TOXOPLASMA GONDII
topic RHOPTRY PROTEINS
THIAZOLIDINONE
TOXOPLASMA GONDII
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Background: Thiazolidinone derivatives show inhibitory activity (IC 50 ) against the Toxoplasma gondii parasite, as well as high selectivity with high therapeutic index. To disclose the target proteins of the thiazolidinone core in this parasite, we explored in silico the active sites of different T. gondii proteins and estimated the binding-free energy of reported thiazolidinone molecules with inhibitory effect on invasion and replication of the parasite inside host cells. This enabled us to describe some of the most suitable structural characteristics to design a compound derived from the thiazolidinone core. Results: The best binding affinity was observed in the active site of kinase proteins, we selected the active site of the T. gondii ROP18 kinase, because it is an important factor for the virulence and survival of the parasite. We present the possible effect of a derivative of thiazolidinone core in the active site of T. gondii ROP18 and described some characteristics of substituent groups that could improve the affinity and specificity of compounds derived from the thiazolidinone core against T. gondii. Conclusions: The results of our study suggest that compounds derived from the thiazolidinone core have a preference for protein kinases of T. gondii, being promising compounds for the development of new drugs with potential anti-toxoplasmosis activity. Our findings highlight the importance of use computational studies for the understanding of the action mechanism of compounds with biological activity.
Fil: Molina, Diego. Universidad del Quindio; Colombia
Fil: Cossio Pérez, Rodrigo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Quilmes. Departamento de Ciencia y Tecnología; Argentina
Fil: Rocha Roa, Cristian Camilo. Universidad del Quindío; Armenia
Fil: Pedraza, Lina. Universidad del Quindio; Colombia
Fil: Cortes, Edwar. Universidad del Quindio; Colombia
Fil: Hernández, Alejandro. Universidad del Quindio; Colombia
Fil: Gómez Marín, Jorge E.. Universidad del Quindio; Colombia
description Background: Thiazolidinone derivatives show inhibitory activity (IC 50 ) against the Toxoplasma gondii parasite, as well as high selectivity with high therapeutic index. To disclose the target proteins of the thiazolidinone core in this parasite, we explored in silico the active sites of different T. gondii proteins and estimated the binding-free energy of reported thiazolidinone molecules with inhibitory effect on invasion and replication of the parasite inside host cells. This enabled us to describe some of the most suitable structural characteristics to design a compound derived from the thiazolidinone core. Results: The best binding affinity was observed in the active site of kinase proteins, we selected the active site of the T. gondii ROP18 kinase, because it is an important factor for the virulence and survival of the parasite. We present the possible effect of a derivative of thiazolidinone core in the active site of T. gondii ROP18 and described some characteristics of substituent groups that could improve the affinity and specificity of compounds derived from the thiazolidinone core against T. gondii. Conclusions: The results of our study suggest that compounds derived from the thiazolidinone core have a preference for protein kinases of T. gondii, being promising compounds for the development of new drugs with potential anti-toxoplasmosis activity. Our findings highlight the importance of use computational studies for the understanding of the action mechanism of compounds with biological activity.
publishDate 2018
dc.date.none.fl_str_mv 2018-11
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/98354
Molina, Diego; Cossio Pérez, Rodrigo; Rocha Roa, Cristian Camilo; Pedraza, Lina; Cortes, Edwar; et al.; Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18 11 Medical and Health Sciences 1108 Medical Microbiology; BioMed Central; BMC Genomics; 19; 1; 11-2018; 1-18
1471-2164
CONICET Digital
CONICET
url http://hdl.handle.net/11336/98354
identifier_str_mv Molina, Diego; Cossio Pérez, Rodrigo; Rocha Roa, Cristian Camilo; Pedraza, Lina; Cortes, Edwar; et al.; Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18 11 Medical and Health Sciences 1108 Medical Microbiology; BioMed Central; BMC Genomics; 19; 1; 11-2018; 1-18
1471-2164
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1186/s12864-018-5223-7
info:eu-repo/semantics/altIdentifier/url/https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-018-5223-7
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1874774419603193856
score 13.334379